© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Biocon to go Ahead with Syngene IPO, Listing Likely in July
Posted 19th May 2015

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biotechnology major Biocon on Wednesday filed a prospectus with market regulator Securities and Exchange Board of India (Sebi) for the Initial Public Offer (IPO) of its research arm, Syngene, through which it aims to raise around Rs 600 crore for funding research and development (R&D).

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biocon to go Ahead with Syngene IPO, Listing Likely in July

View Biography
Amarchand & Mangaldas

Biopharmaceuticals major Biocon on Tuesday said that the unlocking of the value from its contract research subsidiary Syngene would help the company fund its research and development programmes.

Syngene has already filed the draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), seeking approval for an initial public offering (IPO). The company is estimated to be raising around Rs 600 crore through this public issue.

“We are unlocking value from Syngene to fund our R&D programmes, which include a rich pipeline of biosimilars and novel biologics. This fund infusion will help accelerate these programmes which are at various stages of development currently,” said Kiran Mazumdar-Shaw, chairperson and managing director, Biocon.

This is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene. Biocon along with its subsidiary Biocon Research Limited (BRL), currently holds an 84.5 per cent equity stake in Syngene. The company is offering to sell up to 22 million equity shares of face value of Rs 10 each, through Syngene’s IPO.

The offer includes a reservation of two million equity shares for Biocon’s public equity shareholders, being individuals and Hindu Undivided Families (HUFs). The offer would constitute 11 per cent of the post offer paid-up equity share capital of the company.

Established in 1993, Syngene offers a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. The company’s service offerings also support the development of biosimilar and generic molecules.

During the nine months period-ended December 31, 2014, Syngene serviced 195 clients, ranging from multinational corporations to start-ups, including seven of the top 10 global pharmaceutical companies by sales for 2014.

Syngene had reported revenues of Rs 707.7 crore for the previous financial year-ended March 31, 2014 and Rs 617.5 crore for the nine months period ended December 31, 2014. Earlier this month, the company appointed Peter Bains as its Chief Executive Officer. Bains has been a part of Syngene since January 2010 as a director and has more than two decades of experience in the pharmaceutical space.

“Syngene has a proven track record of providing quality NME discovery, development and manufacturing services. It has long-standing partnerships with three of the world’s leading global healthcare organisations, including Bristol-Myers Squibb Co. and has attracted equity participation from India Value Fund recently, which is reflective of the scale, the value and the quality of the differentiated business model of Syngene,” added Mazumdar-Shaw.

Categories: Finance


You Might Also Like
Read Full PostRead - Eye Icon
Empowering Your Accounting Software with AI Capabilities
Finance
03/01/2024Empowering Your Accounting Software with AI Capabilities

According to a recent study by KPMG, over 59% of large organizations already use AI in their financial, accounting, and tax departments and about 29% plan to implement AI-powered software within the next 12 months.

Read Full PostRead - Eye Icon
AI and ESG: Where Do They Overlap?
Corporate Social Responsibility
06/11/2023AI and ESG: Where Do They Overlap?

AI and ESG are two boardroom topics that have more in common than you might think.

Read Full PostRead - Eye Icon
Getting Your Business Transactions Ready: Implementing a Legal Risk Framework
Finance
04/11/2024Getting Your Business Transactions Ready: Implementing a Legal Risk Framework

As a business leader preparing for a potential acquisition or sale, it’s crucial to ensure your company is transaction-ready.

Read Full PostRead - Eye Icon
10 Steps to Prepare Your Business for a Sale
News
17/01/202410 Steps to Prepare Your Business for a Sale

As we enter the new year, a natural time for reflection is approaching – and many business owners may start giving serious thought to what the future holds for their company.

Read Full PostRead - Eye Icon
8 Best Corporate Event Planning Companies in New York for 2026
Strategy
21/10/20268 Best Corporate Event Planning Companies in New York for 2026

A leadership summit in Manhattan has no rehearsal day. The venue contract, the AV crew, the speaker run of show and the guest list all have to land on the same evening, usually in a city where the best rooms book out months ahead. That is why the choice of pla

Read Full PostRead - Eye Icon
2016’s Most Innovative Hedge Fund Manager, Singapore
Finance
01/07/20162016’s Most Innovative Hedge Fund Manager, Singapore

APS Asset Management was founded in 1995 by its CIO, Wong Kok Hoi, in Singapore. In what started as a pioneer among home-grown boutiques, the firm has continued to go from strength to strength.

Read Full PostRead - Eye Icon
Most Innovative Law Firm of 2016, Swansea
Legal
04/04/2016Most Innovative Law Firm of 2016, Swansea

The Most Innovative Law Firm of 2016, Swansea was awarded to ALEXANDRA CHAMBERS.

Read Full PostRead - Eye Icon
Kelly Stone Leads the Way as Best Family Support NPO Business Leader (Canada)
Corporate Social Responsibility
05/01/2021Kelly Stone Leads the Way as Best Family Support NPO Business Leader (Canada)

In 2014, Kelly Stone transformed a decaying national charity into Families Canada—the go-to place for those who work with vulnerable families. Now President and CEO, Kelly is steering Families Canada through a full digital transformation. In addition to a lo

Read Full PostRead - Eye Icon
The Importance of Branding in Building a Strong Business Identity
News
16/08/2023The Importance of Branding in Building a Strong Business Identity

Every day, we come across a number of new brands, whether online or in the physical realm.  While this vast variety benefits consumers, granting them numerous choices, it presents a challenge for businesses striving to distinguish themselves in the bustling s



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow